Endpoints News
Fund & Investor Interest: A new venture fund amid a pandemic? In the Nordics? Eir Ventures brings it on with €76M first close
Endpoints News


From Pharmacia and Lundbeck to Novo Nordisk and AstraZeneca, the Nordic countries have been the birthplace for some legacy pharma companies. But for all that history and reputation, Stephan Christgau counts only five specialized life science investors backing biotechs today.

That leaves plenty of room for Eir Ventures, a brand new venture fund Christgau — one of the founders of Novo Seeds — is launching with three other veteran VCs.

Full Article at Endpoints News